| Stage | CAT | % of rev | FOXA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $4.6B | 100.00% | CAT ×4.52 |
| Gross profit | $7.3B | 35.54% | $4.6B | 100.00% | FOXA +64.5pp |
| Operating income | $4.2B | 20.38% | $1.5B | 32.95% | FOXA +12.6pp |
| Pre-tax income | $4.2B | 20.40% | $1.3B | 28.07% | FOXA +7.7pp |
| Net income | $3.3B | 15.89% | $957M | 20.94% | FOXA +5.0pp |
| Stage | CAT | FOXA | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $4.6B100.00% | CAT ×4.52 |
| Gross profit | 35.54%$7.3B | 100.00%$4.6B | FOXA +64.5pp |
| Operating income | 20.38%$4.2B | 32.95%$1.5B | FOXA +12.6pp |
| Pre-tax income | 20.40%$4.2B | 28.07%$1.3B | FOXA +7.7pp |
| Net income |
| 15.89%$3.3B |
| 20.94%$957M |
| FOXA +5.0pp |
No shared counterparties.